Aptus Pharma Ltd

BSE: 544529 · Pharmaceuticals & Biotechnology · 30 announcements

Share price: ₹480.00
Market cap: ₹823.2 Cr
Revenue (annual): ₹46.57 Cr
Net profit (annual): ₹4.62 Cr
P/E (TTM): 178.2×Sector 43.8×
Promoter holding: 72.89%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

20 Oct 2026 19:01 IST BSE

Aptus Pharma H1 FY27 Results: Net Profit ₹5.1 Cr, Up 200.0% YoY

Aptus Pharma Ltd reported revenue from operations of ₹48.9 Cr (+239.6% YoY) and net profit of ₹5.1 Cr (+200.0% YoY) for H1 FY27.

Key figure: Net profit ₹5.1 Cr · +200.0% YoY

Open full results → Read the story on ALFA News Read the filing ↗

27 Apr 2026 19:42 IST BSE

Financial ResultsAlfa Alert

Aptus Pharma H2 FY26 Results: Net Profit ₹2.9 Cr, Up 61.1% YoY

Aptus Pharma Ltd reported revenue from operations of ₹32.2 Cr (+117.6% YoY) and net profit of ₹2.9 Cr (+61.1% YoY) for H2 FY26.

Key figure: Net profit ₹2.9 Cr · +61.1% YoY

Open full results → Read the filing ↗

27 Apr 2026 19:41 IST BSE

Financial Results

Aptus Pharma Financial Results

Aptus Pharma Limited reported a revenue of ₹46.57 Crore and a net profit of ₹4.62 Crore for the financial year ended March 31, 2026. The Board also fixed May 12, 2026, as the record date for a 3:2 bonus share issue, following shareholder approval via postal ballot.

Value: ₹46.57 Cr

Open announcement → Read the filing ↗